360彩票网

搜索全部
  • 产品中心
  • 专项研究
  • 资料下载
免费咨询电话:

400-627-9288

ZIXUNZHONGXIN

热烈祝贺上海六院罗全勇课题组相关研究在《Theranostics》杂志上发表【附专家点评】2019-4-24

2017年2月23日,国际知名学术期刊Theranostics[IF:8.854]发表上海交通大学附属第六人民医院(上海市第六人民医院)核医学科罗全勇教授课题组的文章”Obatoclax and LY3009120 Efficiently Overcome Vemurafenib Resistance in Differentiated Thyroid Cancer”. 文章展示了在分化型甲状腺癌(Differentiated thyroid cancer, DTC)小分子抑制剂靶向治疗方面的研究取得新进展。


WENZHANGSHIYONGLEJIMANSHENGWUGFP-RFP-LC3SHUANGBIAOZISHIMANBINGDUCHANPIN【HUOHAO:GM-1314L204H-S】。

1.    Wei et al. Obatoclax and LY3009120 Efficiently Overcome Vemurafenib Resistance in Differentiated Thyroid Cancer. Theranostics360彩票网, 2017; 7(4): 987-1001. doi: 10.7150/thno.17322. 

专家点评:


DIANPINGZHUANJIA:FANGUOHUANG,2005NIANZHONGKEYUANBAIRENJIHUARUXUANZHE,2002NIANDUGUOJIAZIRANKEXUEJIANGHUODEZHE,NANCHANGDAXUETEPINJIAOSHOU,ZHUANHUAYIXUEYANJIUYUANFUYUANZHANG。

360彩票网 FENHUAXINGJIAZHUANGXIANAISUIRANZONGTIYUHOUJIAOQITAEXINGZHONGLIUHAO,RENGRANYOUYIBUFENHUANZHEYOUYUZHONGLIUDEDIFENHUAXINGCHUXIANZHONGLIUZHUANYI。DUIYUJIAZHUANGXIANAIXIEDAIBRAF-V600ETUBIANDEHUANZHE,BRAFDEYIZHIJIWEILUOFEINI(Vermurafenib)YOUJIAOHAODELIAOXIAO,DANBUFENHUANZHEYONGYAOYIDUANSHIJIANHOUCHUXIANNAIYAOXING,CONGERYANZHONGXIANZHILELINCHUANGLIAOXIAO。SHANGHAIJIAOTONGDAXUEDILIURENMINYIYUAN Qiu Zhong-Ling (QIUZHONGLING)HE Luo Kuan-yong (LUOQUANYONG)JIAOSHOUZHENDUIBRAF-V600ETUBIANDEJIAZHUANGXIANAIHUANZHEDUIWEILUOFEINIDENAIYAOXINGJINXINGLESHENRUDEYANJIU,FAXIANZHONGLIUXIBAOZHONGBRAFHECRAFXINGCHENGERJUTISHIDUIWEILUOFEINICHANSHENGNAIYAOXINGDEZHONGYAOYUANYIN。TAMENJINYIBUFAXIAN,BCL-2JIEKANGJIObatoclaxHEXINXINGGUANGPURAFYIZHIJILY3009120LIANHEYINGYONGNENGYOUXIAODIYIZHIWEILUOFEINIDIKANGDEJIAZHUANGXIANAIXIBAODEZENGZHI,BINGCUJINQIDIAOWANG。ZHEISHIYIXIANGJUYOUZHONGYAOYIYIDEYANJIUCHENGGUO,YOUKENENGXIANZHUGAISHANNAIYAOXINGJIAZHUANGXIANAIDELINCHUANGLIAOXIAO,ZHIDEJINXINGSHENRUDELINCHUANGYANJIU,BINGJIAYITUIGUANG。

DENGLU

还没有帐号 注册

ZHUCE

<返回登录